Last reviewed · How we verify
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 is a Small molecule drug developed by National Heart, Lung, and Blood Institute (NHLBI). It is currently in Phase 1 development. Also known as: Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag.
At a glance
| Generic name | Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 |
|---|---|
| Also known as | Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Blood bilirubin increased
- Alanine aminotransferase increased
- Abdominal pain
- Aspartate aminotransferase increased
- Blood bilirubin increased (intermittent)
- Edema limbs
- Gastroesophageal reflux disease
- Allergic reaction
- Atrial fibrillation
- Back pain
- Blurred vision
- CPK increased
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 CI brief — competitive landscape report
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 updates RSS · CI watch RSS
- National Heart, Lung, and Blood Institute (NHLBI) portfolio CI
Frequently asked questions about Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
What is Cohort 1: hATG, CsA, EPAG Day 14 to Month 6?
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 is a Small molecule drug developed by National Heart, Lung, and Blood Institute (NHLBI).
Who makes Cohort 1: hATG, CsA, EPAG Day 14 to Month 6?
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 is developed by National Heart, Lung, and Blood Institute (NHLBI) (see full National Heart, Lung, and Blood Institute (NHLBI) pipeline at /company/national-heart-lung-and-blood-institute-nhlbi).
Is Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 also known as anything else?
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 is also known as Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag.
What development phase is Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 in?
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 is in Phase 1.
What are the side effects of Cohort 1: hATG, CsA, EPAG Day 14 to Month 6?
Common side effects of Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 include Blood bilirubin increased, Alanine aminotransferase increased, Abdominal pain, Aspartate aminotransferase increased, Blood bilirubin increased (intermittent), Edema limbs.
Related
- Manufacturer: National Heart, Lung, and Blood Institute (NHLBI) — full pipeline
- Also known as: Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag
- Compare: Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 vs similar drugs
- Pricing: Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 cost, discount & access